RNA editing signature during myeloid leukemia cell differentiation. 2017

C Rossetti, and E Picardi, and M Ye, and G Camilli, and A M D'Erchia, and L Cucina, and F Locatelli, and L Fianchi, and L Teofili, and G Pesole, and A Gallo, and R Sorrentino
Department of Biology and Biotechnology 'Charles Darwin', University La Sapienza, Rome, Italy.

Adenosine deaminases acting on RNA (ADARs) are key proteins for hematopoietic stem cell self-renewal and for survival of differentiating progenitor cells. However, their specific role in myeloid cell maturation has been poorly investigated. Here we show that ADAR1 is present at basal level in the primary myeloid leukemia cells obtained from patients at diagnosis as well as in myeloid U-937 and THP1 cell lines and its expression correlates with the editing levels. Upon phorbol-myristate acetate or Vitamin D3/granulocyte macrophage colony-stimulating factor (GM-CSF)-driven differentiation, both ADAR1 and ADAR2 enzymes are upregulated, with a concomitant global increase of A-to-I RNA editing. ADAR1 silencing caused an editing decrease at specific ADAR1 target genes, without, however, interfering with cell differentiation or with ADAR2 activity. Remarkably, ADAR2 is absent in the undifferentiated cell stage, due to its elimination through the ubiquitin-proteasome pathway, being strongly upregulated at the end of the differentiation process. Of note, peripheral blood monocytes display editing events at the selected targets similar to those found in differentiated cell lines. Taken together, the data indicate that ADAR enzymes play important and distinct roles in myeloid cells.

UI MeSH Term Description Entries
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002762 Cholecalciferol Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24. Vitamin D 3,(3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol,Calciol,Cholecalciferols,Vitamin D3
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000243 Adenosine Deaminase An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA. Adenosine Aminohydrolase,Aminohydrolase, Adenosine,Deaminase, Adenosine
D015973 Gene Expression Regulation, Leukemic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in leukemia. Leukemic Gene Expression Regulation,Regulation of Gene Expression, Leukemic,Regulation, Gene Expression, Leukemic
D016000 Cluster Analysis A set of statistical methods used to group variables or observations into strongly inter-related subgroups. In epidemiology, it may be used to analyze a closely grouped series of events or cases of disease or other health-related phenomenon with well-defined distribution patterns in relation to time or place or both. Clustering,Analyses, Cluster,Analysis, Cluster,Cluster Analyses,Clusterings
D016178 Granulocyte-Macrophage Colony-Stimulating Factor An acidic glycoprotein of MW 23 kDa with internal disulfide bonds. The protein is produced in response to a number of inflammatory mediators by mesenchymal cells present in the hemopoietic environment and at peripheral sites of inflammation. GM-CSF is able to stimulate the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from fetal liver progenitor cells. GM-CSF can also stimulate some functional activities in mature granulocytes and macrophages. CSF-GM,Colony-Stimulating Factor, Granulocyte-Macrophage,GM-CSF,Histamine-Producing Cell-Stimulating Factor,CSF-2,TC-GM-CSF,Tumor-Cell Human GM Colony-Stimulating Factor,Cell-Stimulating Factor, Histamine-Producing,Colony Stimulating Factor, Granulocyte Macrophage,Granulocyte Macrophage Colony Stimulating Factor,Histamine Producing Cell Stimulating Factor,Tumor Cell Human GM Colony Stimulating Factor
D016601 RNA-Binding Proteins Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA. Double-Stranded RNA-Binding Protein,Double-Stranded RNA-Binding Proteins,ds RNA-Binding Protein,RNA-Binding Protein,ds RNA-Binding Proteins,Double Stranded RNA Binding Protein,Double Stranded RNA Binding Proteins,Protein, Double-Stranded RNA-Binding,Protein, ds RNA-Binding,RNA Binding Protein,RNA Binding Proteins,RNA-Binding Protein, Double-Stranded,RNA-Binding Protein, ds,RNA-Binding Proteins, Double-Stranded,ds RNA Binding Protein
D017393 RNA Editing A process that changes the nucleotide sequence of mRNA from that of the DNA template encoding it. Some major classes of RNA editing are as follows: 1, the conversion of cytosine to uracil in mRNA; 2, the addition of variable number of guanines at pre-determined sites; and 3, the addition and deletion of uracils, templated by guide-RNAs (RNA, GUIDE, KINETOPLASTIDA). RNA, Messenger, Editing,Editing, RNA,Editings, RNA,RNA Editings

Related Publications

C Rossetti, and E Picardi, and M Ye, and G Camilli, and A M D'Erchia, and L Cucina, and F Locatelli, and L Fianchi, and L Teofili, and G Pesole, and A Gallo, and R Sorrentino
December 1979, Cancer letters,
C Rossetti, and E Picardi, and M Ye, and G Camilli, and A M D'Erchia, and L Cucina, and F Locatelli, and L Fianchi, and L Teofili, and G Pesole, and A Gallo, and R Sorrentino
July 1996, European journal of haematology,
C Rossetti, and E Picardi, and M Ye, and G Camilli, and A M D'Erchia, and L Cucina, and F Locatelli, and L Fianchi, and L Teofili, and G Pesole, and A Gallo, and R Sorrentino
December 1988, Leukemia,
C Rossetti, and E Picardi, and M Ye, and G Camilli, and A M D'Erchia, and L Cucina, and F Locatelli, and L Fianchi, and L Teofili, and G Pesole, and A Gallo, and R Sorrentino
January 1973, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
C Rossetti, and E Picardi, and M Ye, and G Camilli, and A M D'Erchia, and L Cucina, and F Locatelli, and L Fianchi, and L Teofili, and G Pesole, and A Gallo, and R Sorrentino
August 1982, Biochemical and biophysical research communications,
C Rossetti, and E Picardi, and M Ye, and G Camilli, and A M D'Erchia, and L Cucina, and F Locatelli, and L Fianchi, and L Teofili, and G Pesole, and A Gallo, and R Sorrentino
March 2017, Nucleus (Austin, Tex.),
C Rossetti, and E Picardi, and M Ye, and G Camilli, and A M D'Erchia, and L Cucina, and F Locatelli, and L Fianchi, and L Teofili, and G Pesole, and A Gallo, and R Sorrentino
December 2014, Leukemia supplements,
C Rossetti, and E Picardi, and M Ye, and G Camilli, and A M D'Erchia, and L Cucina, and F Locatelli, and L Fianchi, and L Teofili, and G Pesole, and A Gallo, and R Sorrentino
December 1969, Journal of cellular physiology,
C Rossetti, and E Picardi, and M Ye, and G Camilli, and A M D'Erchia, and L Cucina, and F Locatelli, and L Fianchi, and L Teofili, and G Pesole, and A Gallo, and R Sorrentino
January 2012, Leukemia research and treatment,
C Rossetti, and E Picardi, and M Ye, and G Camilli, and A M D'Erchia, and L Cucina, and F Locatelli, and L Fianchi, and L Teofili, and G Pesole, and A Gallo, and R Sorrentino
June 1991, Human cell,
Copied contents to your clipboard!